Sentien Biotechnologies
VerifiedA Cambridge, MA and Lexington, MA based regenerative medicine company developing cell based therapies for critical care diseases.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$48—72m (Dealroom.co estimates Apr 2017.)
Lexington Kentucky (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | $0.0 | round |
| N/A | $0.0 | round | |
| N/A | $0.0 | round | |
| N/A | $0.0 | round | |
| N/A | $0.0 | round | |
| investor | $0.0 | round | |
$12.0m | Series A | ||
| Total Funding | 000k | ||
Related Content
Recent News about Sentien Biotechnologies
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.